7.63  -0.02 (-0.26%)		06-15 16:00
Open: 7.45 High: 7.73 Volume: 8,469		Pre. Close: 7.65 Low: 7.375 Market Cap: 6(M)

Short term
Mid term
Targets	6-month :	10.8	1-year :	12.81
Resists	First :	9.25	Second :	10.97
Pivot price	7.38
Supports	First :	6.46	Second :	5.37
MAs	MA(5) :	7.39	MA(20) :	7.45
	MA(100) :	8.5	MA(250) :	19.93
MACD	MACD :	-0.3	Signal :	-0.3
%K %D	K(14,3) :	37.9	D(3) :	32.9
RSI	RSI(14): 49
52-week	High :	120	Low :	3.07

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MLEC ] has closed below upper band by 32.8%. Bollinger Bands are 78.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	7.74 - 7.78	7.78 - 7.8
Low:	7.28 - 7.33	7.33 - 7.37
Close:	7.56 - 7.63	7.63 - 7.68

Moolec Science S.A. is an innovative biotechnology firm specializing in the development of plant-grown animal proteins. Leveraging a transformative method called Molecular Farming, the company is poised to disrupt the alternative protein market. Their product lines and research and development efforts capitalize on the inherent agricultural benefits of select host crops, such as soybeans and peas. Globally, Moolec maintains operations across the United States, Europe, and South America. Established in 2008, the company is headquartered in Luxembourg.

Thu, 11 Jun 2026
Number of shareholders of Moolec Science SA – NASDAQ:MLEC - TradingView

Tue, 02 Jun 2026
Moolec Science (MLEC) restores Nasdaq listing compliance but faces year of monitoring - Stock Titan

Tue, 07 Apr 2026
Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds - ACCESS Newswire

Mon, 06 Apr 2026
MLEC’s Insider News Sends Ripples Through the Market - timothysykes.com

Mon, 06 Apr 2026
MLEC Stock Extends Its Relentless Rally, Sees 35% Boost Today After Change In Shareholding - Stocktwits

Fri, 13 Feb 2026
Engineered safflower harvest boosts GLA yields 57% in U.S. - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	1 (M)
Shares Float	0 (M)
Held by Insiders	21 (%)
Held by Institutions	2.2 (%)
Shares Short	9 (K)
Shares Short P.Month	114 (K)

EPS	-199.03
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.69
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.04
PEG Ratio	0
Price to Book value	10.9
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.